SCHEMBL23768828

SCHEMBL23768828

O=C(Nc1ccc2c(c1)N(c1ccccc1)C(=O)CO2)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRA6 Q16445 1/20 0.41
P2RX4 Q99571 1/20 0.41
PYGL P06737 1/20 0.39
ESR1 P03372 5/20 0.39
MAOA P21397 1/20 0.39
NOTUM Q6P988 1/20 0.39
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
FPR2 P25090 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CDK8 P49336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29979369 1.00 CFTR (0.41) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL23769049 0.92 P2RX4 (0.45) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL29979030 0.92 P2RX4 (0.45) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL29978948 0.81 TRPV1 (0.43) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL23768832 0.81 TRPV1 (0.43) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL23769073 0.78 ITGB3 (0.51) TDP1CDK8
SCHEMBL29979318 0.78 ITGB3 (0.51) TDP1CDK8
SCHEMBL23769501 0.78 P2RX4 (0.43) P2RX4MAOANPC1MAPTRAB9A
SCHEMBL27375907 0.75 NPC1 (0.61) CFTRGABRA1GABRB1GABRA5GABRA3
SCHEMBL23769056 0.75 MAPT (0.41) CFTRGABRA1GABRB1GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS CFTR 482/4885GABRA1 3861/4885GABRB1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.